Abstract
Prevention or alleviation of pain in laboratory mice is a fundamental requirement of in vivo research. The mouse grimace scale (MGS) has the potential to be an effective and rapid means of assessing pain and analgesic efficacy in laboratory mice. Preliminary studies have demonstrated its potential utility for assessing pain in mouse models that involve potentially painful procedures. The next step in validation is to determine if the other procedures that are integral to these models, i.e. anaesthesia or analgesia, result in any changes in MGS score which would need to be taken into account when using this tool to assess post-procedural pain. Here, spontaneous behaviour and MGS data for CBA and DBA/2 mice were recorded at baseline and following either isoflurane anaesthesia (suitable to perform abdominal surgery) or 0.05mg/kgs.c. buprenorphine. In line with previous studies, isoflurane anaesthesia alone had limited effects on the spontaneous behaviour in either strain of mice. Administration of buprenorphine resulted in increased periods of activity e.g. walking and chewing bedding in CBA mice. These effects were not demonstrated in DBA/2 mice. In comparison, buprenorphine alone had no impact on MGS score in either strain of mice, however DBA/2 mice showed a significant increase in MGS score following isoflurane anaesthesia. The presence of this increased MGS score must be taken into account when attempting to use the MGS to assess pain in DBA/2 mice. Further work should be carried out to establish the presence of this isoflurane effect in other strains and the potential influence of gender on the MGS. This further validation is necessary prior to implementation of this technique in clinical scenarios.
Highlights
Prevention or alleviation of pain in laboratory animals is a fundamental requirement of in vivo research
In CBA mice, there was no significant difference in mouse grimace scale (MGS) scores between baseline compared to either post isoflurane anaesthesia or the buprenorphine administration
In DBA/2 mice, there was no significant difference in MGS scores at baseline compared to post buprenorphine administration
Summary
Prevention or alleviation of pain in laboratory animals is a fundamental requirement of in vivo research This is critical for laboratory mice, as they comprise the greatest number of animals used, and this number is increasing annually with the growth of research using genetically modified models (Home Office, 2012). With this increasing diversity of mouse strains and models in common use, we need to ensure that our means of assessing pain and analgesic efficacy are both effective and clinically applicable across mouse strains. Spontaneous ‘pain’ behaviour and facial expressions have been investigated as a means of effectively assessing pain in laboratory mice (e.g. Leach et al, 2012; Miller et al, 2012; Wright-Williams et al, 2013)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
